Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Latest From Tina Tan
In its latest and biggest fundraising to date, Moximed has bagged $50m in a series C round, which will help the company take its joint-unloading technology for osteoarthritis patients through US approval and into early commercialization.
One in five medtech companies in Europe feel they are not capable of fully monetizing innovations they are putting out into the marketplace, according to Simon-Kucher & Partner's latest "Medtech Barometer" report. Subsequently, firms are not offsetting losses arising from persistent price erosion, and this is impacting profit growth, the survey findings suggest.
RenalGuard Solutions has attracted $14.5m from investors and will use the funds to take its novel device, designed to prevent acute kidney injury following cardiac interventional procedures, into the US.
A 10-partner research project has won a €4m EU grant to develop a wearable surgical robotic system, the first of its kind. The leader of the project, Sanja Dogramadzi of the Bristol Robotics Laboratory, provided more details on how this new technology would improve on existing systems like Intuitive Surgical's leading da Vinci.
$30m is the amount of equity financing raised by Cardiva Medical to fund commercialization of its VASCADE vascular closure system.
The HCV testing paradigm has changed since the advent of direct-acting antiviral drugs. genedrive PLC is looking to capitalize on this growth opportunity with its hepatitis C test, designed for decentralized use in resource-limited settings.